⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Pictura Bio and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Pictura Bio
↗Oxford, United Kingdom
Pictura Bio is an Oxford University spin-out medtech company that develops rapid, point-of-care diagnostic platforms for infectious diseases. The company combines single-molecule fluorescent microscopy, proprietary molecular labeling (PIC-ID), and machine learning to identify pathogens in under a minute.
Originally founded as OxDX, the company rebranded to Pictura Bio to reflect its maturing technology and broader diagnostic ambitions. Its core product, the VISTA benchtop device, is designed to provide instantaneous diagnostic results, aiming to replace slow, centralized laboratory testing with efficient, actionable point-of-care solutions.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2022
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:$6.1M
Investors:IQ Capital Partners, Ahren Innovation Capital, Science Creates Ventures, Flu Labs
PIPELINE
Stage:Preclinical
Lead Drug Stage:Prototype/Pre-commercial
Modalities:Diagnostics, AI/Machine Learning, Optical Imaging
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:NHS Portsmouth (Emergency Department trials), Defence and Security Accelerator (DASA) (prototype delivery), Oxford Product Design (engineering and development support)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Alex Batchelor - CEO
Dr. Nicole Robb - Scientific Co-Founder
Dr. Nicolas Shiaelis - Scientific Co-Founder
Scientific Founders:Dr. Nicole Robb, Dr. Nicolas Shiaelis
LINKS
Website:pictura.bio
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Pictura Bio. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.